PACIRA BIOSCIENCES, INC.

PCRX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2009
Operating Activities
Net Income $-31.7M
Depreciation & Amortization $4.1M
Depreciation
Amortization
Stock-Based Compensation $524.0K
Net Cash from Operating Activities $-20.8M
Investing Activities
Capital Expenditures $5.5M
Business Acquisitions
Net Cash from Investing Activities
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities
Net Change in Cash
Free Cash Flow $-26.3M
← Newer Page 3 of 3 Older →